| Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. | |
| | |
MedLine Citation:
|
PMID: 20645075 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION AND HYPOTHESIS: We evaluated the efficacy of transurethral injection (TUI) for the treatment of recurrent or persistent stress urinary incontinence after mid-urethral sling (MUS) procedures. METHODS: A retrospective study was conducted among 23 women who had undergone TUI for failed MUS using bulking agents, Macroplastique® and Durasphere®. The Sandvik questionnaire, Subjective Symptom Visual Analogue Scale (VAS), Incontinence Quality of Life (I-QOL) assessment, and Benefit, Satisfaction, and Willingness to Continue questionnaire were used to evaluate the efficacy of TUI. RESULTS: The cure rate was 34.8% for a median follow-up of 10 months. Subjective symptom VAS, total, and all domains of I-QOL scores were significantly improved after TUI. Ninety-two percent of the patients reported a benefit and 77% of the patients were satisfied with the treatment. CONCLUSIONS: TUI for failed MUS demonstrated a low cure rate but high patient satisfaction, and the procedure was minimally invasive with no significant complications. |
| | |
Authors:
|
Ha Na Lee; Young-Suk Lee; Ji-Yeon Han; Jae Yong Jeong; Myung-Soo Choo; Kyu-Sung Lee |
Related Documents
:
|
22581925 - Higher volume endovascular stroke centers have faster times to treatment, higher reperf... 6492285 - Suprapubic endoscopic vesical neck suspension (stamey procedure) for control of urinary... 10218095 - Pelvic floor rehabilitation in multiple sclerosis. 12232885 - Compliance with recommendations of the urodynamic society for standards of efficacy for... 10789745 - Photodynamic therapy for residual neoplasms of the perianal skin. 10527225 - Duration of preoperative amiodarone treatment may be associated with postoperative hosp... |
Publication Detail:
|
Type: Journal Article Date: 2010-07-20 |
Journal Detail:
|
Title: International urogynecology journal Volume: 21 ISSN: 1433-3023 ISO Abbreviation: Int Urogynecol J Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-10 Completed Date: 2011-03-10 Revised Date: 2011-08-18 |
Medline Journal Info:
|
Nlm Unique ID: 101567041 Medline TA: Int Urogynecol J Country: England |
Other Details:
|
Languages: eng Pagination: 1479-83 Citation Subset: IM |
Affiliation:
|
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Combined Modality Therapy Dimethylpolysiloxanes / administration & dosage, adverse effects, therapeutic use* Equipment Failure* Female Follow-Up Studies Glucans / administration & dosage, adverse effects, therapeutic use* Humans Injections Middle Aged Patient Satisfaction Retrospective Studies Suburethral Slings* Treatment Outcome Urinary Incontinence, Stress / therapy* Zirconium / administration & dosage, adverse effects, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Dimethylpolysiloxanes; 0/Glucans; 0/durasphere; 63148-62-9/baysilon; 7440-67-7/Zirconium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult ...
Next Document: Pelvic pain in urogynaecology. Part I: evaluation, definitions and diagnoses.